Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007, 448: 427-434. 10.1038/nature06005.
Article
CAS
PubMed
Google Scholar
Franke A, Balschun T, Karlsen TH, Hedderich J, May S, Lu T, et al: Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008, 40: 713-715. 10.1038/ng.148.
Article
CAS
PubMed
Google Scholar
Ernst A, Jacobsen B, Ostergaard M, Okkels H, Andersen V, Dagiliene E, et al: Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population. Scand J Gastroenterol. 2007, 42: 1445-1451. 10.1080/00365520701427102.
Article
CAS
PubMed
Google Scholar
A Catalog of Published Genome-Wide Association Studies, Hindorff LA, Junkins HA, Manolio TA: A Catalog of Published Genome-Wide Association Studies. 2008, Accessed [20Feb2010], [http://www.genome.gov/26525384]
Google Scholar
Ostergaard M, Ernst A, Labouriau R, Dagiliene E, Krarup HB, Christensen M, et al: Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population. Scand J Gastroenterol. 2009, 44: 65-73. 10.1080/00365520802400826.
Article
PubMed
Google Scholar
Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, Prescott NJ, et al: Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet. 2008, 40: 710-712. 10.1038/ng.145.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al: Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008, 40: 955-962. 10.1038/ng.175.
Article
CAS
PubMed
PubMed Central
Google Scholar
Duerr RH: Update on the genetics of inflammatory bowel disease. J Clin Gastroenterol. 2003, 37: 358-367. 10.1097/00004836-200311000-00003.
Article
PubMed
Google Scholar
Brant SR, Shugart YY: Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field. Inflamm Bowel Dis. 2004, 10: 300-311. 10.1097/00054725-200405000-00019.
Article
PubMed
Google Scholar
Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M, et al: Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol. 2007, 102: 1259-1267. 10.1111/j.1572-0241.2007.01149.x.
Article
CAS
PubMed
Google Scholar
Baumgart DC, Carding SR: Inflammatory bowel disease: cause and immunobiology. Lancet. 2007, 369: 1627-1640. 10.1016/S0140-6736(07)60750-8.
Article
CAS
PubMed
Google Scholar
Strober W, Fuss I, Mannon P: The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007, 117: 514-521. 10.1172/JCI30587.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fukata M, Abreu MT: What Are Toll-like Receptors and what Role May They Have in IBD. Inflamm Bowel Dis. 2008, 14: S90-S91. 10.1002/ibd.20632.
Article
PubMed
Google Scholar
Werner T, Haller D: Intestinal epithelial cell signalling and chronic inflammation: From the proteome to specific molecular mechanisms. Mutat Res. 2007, 622: 42-57.
Article
CAS
PubMed
Google Scholar
Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009, 27 (519-50): 519-550. 10.1146/annurev.immunol.021908.132612.
Article
CAS
PubMed
Google Scholar
Guimbaud R, Bertrand V, Chauvelot-Moachon L, Quartier G, Vidon N, Giroud JP, et al: Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. Am J Gastroenterol. 1998, 93: 2397-2404. 10.1111/j.1572-0241.1998.00694.x.
Article
CAS
PubMed
Google Scholar
Kidd M, Gustafsson BI, Drozdov I, Modlin IM: IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil. 2009, 21: 439-450. 10.1111/j.1365-2982.2008.01210.x.
Article
CAS
PubMed
Google Scholar
Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, et al: Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 2006, 15: 519-529. 10.1093/hmg/ddi469.
Article
CAS
PubMed
Google Scholar
Hacker UT, Bidlingmaier C, Gomolka M, Keller E, Eigler A, Hartmann G, et al: Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms. Eur J Clin Invest. 1998, 28: 214-219. 10.1046/j.1365-2362.1998.00277.x.
Article
CAS
PubMed
Google Scholar
Corleto VD, Pagnini C, Margagnoni G, Guagnozzi D, Torre MS, Martorelli M, et al: IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies. Dig Liver Dis. 2010, 42: 179-84. 10.1016/j.dld.2009.06.016.
Article
CAS
PubMed
Google Scholar
Ferreira AC, Almeida S, Tavares M, Canedo P, Pereira F, Regalo G, et al: NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm Bowel Dis. 2005, 11: 331-339. 10.1097/01.MIB.0000158153.71579.b4.
Article
PubMed
Google Scholar
Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmud N, et al: Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm. 2004, 13: 181-187. 10.1080/09511920410001713529.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ: Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut. 1998, 43: 33-39. 10.1136/gut.43.1.33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Queiroz DM, Oliveira AG, Saraiva IE, Rocha GA, Rocha AM, das Gracas Pimenta SM, et al: Immune response and gene polymorphism profiles in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2009, 15: 353-358. 10.1002/ibd.20757.
Article
PubMed
Google Scholar
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993, 75: 263-274. 10.1016/0092-8674(93)80068-P.
Article
CAS
PubMed
Google Scholar
Ishizuka K, Sugimura K, Homma T, Matsuzawa J, Mochizuki T, Kobayashi M, et al: Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis. Digestion. 2001, 63 (Suppl 1): 22-7-22-27.
PubMed
Google Scholar
Correa I, Veny M, Esteller M, Pique JM, Yague J, Panes J, et al: Defective IL-10 production in severe phenotypes of Crohn's disease. J Leukoc Biol. 2009, 85: 896-903. 10.1189/jlb.1108698.
Article
CAS
PubMed
Google Scholar
Schreiber S, Heinig T, Thiele HG, Raedler A: Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology. 1995, 108: 1434-1444. 10.1016/0016-5085(95)90692-4.
Article
CAS
PubMed
Google Scholar
Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, et al: Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008, 40: 1319-1323. 10.1038/ng.221.
Article
CAS
PubMed
Google Scholar
Amre DK, Mack DR, Morgan K, Israel D, Lambrette P, Costea I, et al: Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther. 2009, 29: 1025-1031. 10.1111/j.1365-2036.2009.03953.x.
Article
CAS
PubMed
Google Scholar
Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP: Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun. 2000, 1: 185-190. 10.1038/sj.gene.6363657.
Article
CAS
PubMed
Google Scholar
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997, 24: 1-8.
Article
CAS
PubMed
Google Scholar
Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, Vulule JM, et al: Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet. 2008, 124: 515-524. 10.1007/s00439-008-0578-5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, et al: Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA. 2000, 19 (97): 14467-14472. 10.1073/pnas.97.26.14467.
Article
Google Scholar
Fowler EV, Eri R, Hume G, Johnstone S, Pandeya N, Lincoln D, et al: TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet. 2005, 42: 523-528. 10.1136/jmg.2004.027425.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tedde A, Laura PA, Bagnoli S, Congregati C, Milla M, Sorbi S, et al: Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol. 2008, 43: 712-718. 10.1080/00365520701885507.
Article
CAS
PubMed
Google Scholar
Tagore A, Gonsalkorale WM, Pravica V, Hajeer AH, McMahon R, Whorwell PJ, et al: Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens. 1999, 54: 386-390. 10.1034/j.1399-0039.1999.540408.x.
Article
CAS
PubMed
Google Scholar
Fernandez L, Martinez A, Mendoza JL, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, et al: Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis. 2005, 11: 739-743. 10.1097/01.MIB.0000173457.64868.20.
Article
PubMed
Google Scholar
Parkes M, Satsangi J, Jewell D: Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol. 1998, 113: 28-32. 10.1046/j.1365-2249.1998.00625.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, et al: The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis. 2000, 21: 3578-3582. 10.1002/1522-2683(200011)21:17<3578::AID-ELPS3578>3.0.CO;2-Z.
Article
CAS
PubMed
Google Scholar
Pae HO, Kim EC, Chung HT: Integrative survival response evoked by heme oxygenase-1 and heme metabolites. J Clin Biochem Nutr. 2008, 42: 197-203. 10.3164/jcbn.2008029.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee TS, Chau LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002, 8: 240-246. 10.1038/nm0302-240.
Article
CAS
PubMed
Google Scholar
Berberat PO, Rahim YI, Yamashita K, Warny MM, Csizmadia E, Robson SC, et al: Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis. Inflamm Bowel Dis. 2005, 11: 350-359. 10.1097/01.MIB.0000164017.06538.8a.
Article
PubMed
Google Scholar
Paul G, Bataille F, Obermeier F, Bock J, Klebl F, Strauch U, et al: Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol. 2005, 140: 547-555. 10.1111/j.1365-2249.2005.02775.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang WP, Guo X, Koo MW, Wong BC, Lam SK, Ye YN, et al: Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol. 2001, 281: G586-G594.
CAS
PubMed
Google Scholar
Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE: Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med. 2005, 19 (202): 1703-1713. 10.1084/jem.20051047.
Article
Google Scholar
Takagi T, Naito Y, Mizushima K, Nukigi Y, Okada H, Suzuki T, et al: Increased intestinal expression of heme oxygenase-1 and its localization in patients with ulcerative colitis. J Gastroenterol Hepatol. 2008, 23 (Suppl 2): S229-S233. 10.1111/j.1440-1746.2008.05443.x.
Article
CAS
PubMed
Google Scholar
Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, et al: A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis. 2004, 173: 315-319. 10.1016/j.atherosclerosis.2003.11.021.
Article
CAS
PubMed
Google Scholar
Hausmann M, Paul G, Kellermeier S, Frey I, Scholmerich J, Falk W, et al: (GT)N dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease course. Clin Exp Immunol. 2008, 153: 81-85. 10.1111/j.1365-2249.2008.03674.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S: Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006, 81: 1462-1471. 10.4065/81.11.1462.
Article
PubMed
Google Scholar
Kikuchi H, Itoh J, Fukuda S: Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factor. Neurosci Lett. 2008, 432: 217-221. 10.1016/j.neulet.2007.12.027.
Article
CAS
PubMed
Google Scholar
Podolsky DK: Inflammatory bowel disease. N Engl J Med. 2002, 347: 417-429. 10.1056/NEJMra020831.
Article
CAS
PubMed
Google Scholar
Satsangi J, Silverberg MS, Vermeire S, Colombel JF: The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006, 55: 749-753. 10.1136/gut.2005.082909.
Article
CAS
PubMed
PubMed Central
Google Scholar
Macarthur M, Sharp L, Hold GL, Little J, El-Omar EM: The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1613-1618. 10.1158/1055-9965.EPI-04-0878.
Article
CAS
PubMed
Google Scholar
Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, Tjonneland A: Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res. 2007, 617: 138-146.
Article
CAS
PubMed
Google Scholar
Greenland S: Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995, 6: 356-365. 10.1097/00001648-199507000-00005.
Article
CAS
PubMed
Google Scholar
Genetic Power Calculator. 2009, [http://pngu.mgh.harvard.edu/~purcell/gpc/cc2.html]
Tedde A, Laura PA, Bagnoli S, Congregati C, Milla M, Sorbi S, et al: Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol. 2008, 43: 712-718. 10.1080/00365520701885507.
Article
CAS
PubMed
Google Scholar
El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000, 404: 398-402. 10.1038/35006081.
Article
CAS
PubMed
Google Scholar
Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, Raaschou-Nielsen O, et al: Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res. 2008, 639: 89-100.
Article
CAS
PubMed
Google Scholar
Birrenbach T, Bocker U: Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis. 2004, 10: 848-859. 10.1097/00054725-200411000-00019.
Article
PubMed
Google Scholar
Aldhous MC, Prescott RJ, Roberts S, Samuel K, Waterfall M, Satsangi J: Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease?. Inflamm Bowel Dis. 2008, 14: 1469-1482. 10.1002/ibd.20523.
Article
PubMed
Google Scholar
Karban A, Eliakim R: Effect of smoking on inflammatory bowel disease: Is it disease or organ specific?. World J Gastroenterol. 2007, 13: 2150-2152.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fowler EV, Doecke J, Simms LA, Zhao ZZ, Webb PM, Hayward NK, et al: ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity. Am J Gastroenterol. 2008, 103: 2519-2526. 10.1111/j.1572-0241.2008.02023.x.
Article
CAS
PubMed
Google Scholar
Achkar JP, Dassopoulos T, Silverberg MS, Tuvlin JA, Duerr RH, Brant SR, et al: Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am J Gastroenterol. 2006, 101: 572-580. 10.1111/j.1572-0241.2006.00451.x.
Article
CAS
PubMed
Google Scholar
Comments
View archived comments (1)